ArticleCancer research2017

MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia.

Nakhle S Saba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.